Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kukje Pharma
Clinical trial to evaluate the influence of drug and drug-drug interactions of Brimonidine and Dorzolamide co-administration on the pharmacokinetics of Brimonidine and pharmacokinetics of Dorzolamide in healthy volunteers
Age
19–50
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Healthy male adults aged between 19 and 50 during screening period
BMI more than 18kg / m2 and less than 30kg / m2 and weight more than 55kg
Signed the informed consent form prior to study participation.
You may not be if
Presence of medical history or a concurrent disease that may interfere with treatment and safety assessment or completion of this clinical study, including clinically significant disorders in kidney, liver, cardiovascular system, respiratory system, endocrine system, or neuropsychiatric system.
Clareo Health | KJ-TFC-004 Drug-drug Interaction Study
